Moreover, administering recombinant prokineticin 2 to both heterozygous prokineticin 2-deficient mice and wild-type mice prevented sepsis-related mortality and alleviated the multi-organ damage caused by sepsis. The gene discussed is PROK2; the disease is Sepsis.